Effect of phosphodiester composition in polyphosphoesters on the inhibition of osteoclastic differentiation of murine bone marrow mononuclear cells

References

• Reid IR, Billington EO. Drug therapy for osteoporosis in older adults. Lancet. 2022;399(10329):1080–1092. doi: 10.1016/S0140-6736(21)02646-5.
   PubMed Web of Science ®Google Scholar
• Anthamatten A, Parish A. Clinical update on osteoporosis. J Midwifery Womens Health. 2019;64(3):265–275. doi: 10.1111/jmwh.12954.
   PubMed Web of Science ®Google Scholar
• Skjødt MK, Frost M, Abrahamsen B. Side effects of drugs for osteoporosis and metastatic bone disease. Br J Clin Pharmacol. 2019;85(6):1063–1071. doi: 10.1111/bcp.13759.
   PubMed Web of Science ®Google Scholar
• Chen YC, Sosnoski DM, Mastro AM. Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res. 2010;12(6):215. doi: 10.1186/bcr2781.
   PubMed Web of Science ®Google Scholar
• Hofbauer LC, Brueck CC, Singh SK, et al. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res. 2007;22(9):1317–1328. doi: 10.1359/jbmr.070510.
   PubMed Web of Science ®Google Scholar
• Song S, Guo Y, Yang Y, et al. Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacol Ther. 2022;237:108168. doi: 10.1016/j.pharmthera.2022.108168.
   PubMed Web of Science ®Google Scholar
• Gao X, Li L, Cai X, et al. Targeting nanoparticles for diagnosis and therapy of bone tumors: opportunities and challenges. Biomaterials. 2021;265:120404. doi: 10.1016/j.biomaterials.2020.120404.
   PubMed Web of Science ®Google Scholar
• Pan H, Sima M, Kopečková P, et al. Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl)methacrylamide copolymer-alendronate conjugates. Mol Pharm. 2008;5(4):548–558. doi: 10.1021/mp800003u.
   PubMedGoogle Scholar
• Low SA, Kopecek J. Targeting polymer therapeutics to bone. Adv Drug Deliv Rev. 2012;64(12):1189–1204. doi: 10.1016/j.addr.2012.01.012.
   PubMed Web of Science ®Google Scholar
• Segal E, Pan H, Ofek P, et al. Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics. PLoS One. 2009;4(4):e5233. doi: 10.1371/journal.pone.0005233.
   PubMed Web of Science ®Google Scholar
• Lei C, Song JH, Li S, et al. Advances in materials-based therapeutic strategies against osteoporosis. Biomaterials. 2023;296:122066. doi: 10.1016/j.biomaterials.2023.122066.
   PubMed Web of Science ®Google Scholar
• Zhou X, Cornel EJ, Fan Z, et al. Bone-targeting polymer vesicles for effective therapy of osteoporosis. Nano Lett. 2021;21(19):7998–8007. doi: 10.1021/acs.nanolett.1c02150.
   PubMed Web of Science ®Google Scholar
• Penczek S, Pretula J, Kubisa P, et al. Reactions of H3PO4 forming polymers. Apparently simple reactions leading to sophisticated structures and applications. Prog Polym Sci. 2015;45:44–70. doi: 10.1016/j.progpolymsci.2015.01.001.
   Web of Science ®Google Scholar
• Iwasaki Y, Yamaguchi E. Synthesis of well-defined thermoresponsive polyphosphoester macroinitiators using organocatalysts. Macromolecules. 2010;43(6):2664–2666. doi: 10.1021/ma100242s.
   Web of Science ®Google Scholar
• Zhao Z, Wang J, Mao H-Q, et al. Polyphosphoesters in drug and gene delivery. Adv Drug Deliv Rev. 2003;55(4):483–499. doi: 10.1016/s0169-409x(03)00040-1.
   PubMed Web of Science ®Google Scholar
• Wang S, Wan ACA, Xu X, et al. A new nerve guide conduit material composed of a biodegradable poly(phosphoester). Biomaterials. 2001;22(10):1157–1169. doi: 10.1016/s0142-9612(00)00356-2.
   PubMed Web of Science ®Google Scholar
• Bauer KN, Tee HT, Velencoso MM, et al. Main-chain poly(phosphoester)s: history, syntheses, degradation, bio-and flame-retardant applications. Prog Polym Sci. 2017;73:61–122. doi: 10.1016/j.progpolymsci.2017.05.004.
   Web of Science ®Google Scholar
• Pelosi C, Tinè MR, Wurm FR. Main-chain water-soluble polyphosphoesters: multi-functional polymers as degradable PEG-alternatives for biomedical applications. Eur Polym J. 2020;141:110079. doi: 10.1016/j.eurpolymj.2020.110079.
   Web of Science ®Google Scholar
• Baran J, Penczek S. Hydrolysis of polyesters of phosphoric acid. 1. Kinetics and the pH profile. Macromolecules. 1995;28(15):5167–5176. doi: 10.1021/ma00119a002.
   Web of Science ®Google Scholar
• Rheinberger T, Wolfs J, Paneth A, et al. RNA-inspired and accelerated degradation of polylactide in seawater. J Am Chem Soc. 2021;143(40):16673–16681. doi: 10.1021/jacs.1c07508.
   PubMed Web of Science ®Google Scholar
• Haider TP, Suraeva O, Lieberwirth I, et al. RNA-inspired intramolecular transesterification accelerates the hydrolysis of polyethylene-like polyphosphoesters. Chem Sci. 2021;12(48):16054–16064. doi: 10.1039/d1sc05509g.
   PubMed Web of Science ®Google Scholar
• Iwasaki Y, Katayama K, Yoshida M, et al. Comparative physicochemical properties and cytotoxicity of polyphosphoester ionomers with bisphosphonates. J Biomater Sci Polym Ed. 2013;24(7):882–895. doi: 10.1080/09205063.2012.710823.
   PubMed Web of Science ®Google Scholar
• Iwasaki Y, Yokota A, Otaka A, et al. Bone-targeting poly(ethylene sodium phosphate). Biomater Sci. 2017;6(1):91–95. doi: 10.1039/c7bm00930e.
   PubMed Web of Science ®Google Scholar
• Otaka A, Kiyono K, Iwasaki Y. Enhancement of osteoblast differentiation using poly(ethylene sodium phosphate). Materialia. 2021;15:100977. doi: 10.1016/j.mtla.2020.100977.
   Web of Science ®Google Scholar
• Kiyono K, Mabuchi S, Otaka A, et al. Bone-targeting polyphosphodiesters that promote osteoblastic differentiation. J Biomed Mater Res A. 2023;111(5):714–724. doi: 10.1002/jbm.a.37499.
   PubMed Web of Science ®Google Scholar
• Kootala S, Tokunaga M, Hilborn J, et al. Anti-resorptive functions of poly(ethylene sodium phosphate) on human osteoclasts. Macromol Biosci. 2015;15(12):1634–1640. doi: 10.1002/mabi.201500166.
   PubMed Web of Science ®Google Scholar
• Steinbach T, Schröder R, Ritz S, et al. Microstructure analysis of biocompatible phosphoester copolymers. Polym Chem. 2013;4(16):4469–4479. doi: 10.1039/c3py00563a.
   Web of Science ®Google Scholar
• Iwasaki Y, Kawakita T, Yusa S-I. Thermoresponsive polyphosphoesters bearing enzyme-cleavable side chains. Chem Lett. 2009;38(11):1054–1055. doi: 10.1246/cl.2009.1054.
   Web of Science ®Google Scholar
• Wagner M, Koester H, Deffge C, et al. Isolation and intravenous injection of murine bone marrow derived monocytes. J Vis Exp. 2014;94:e52347. doi: 10.3791/52347.
   Google Scholar
• Iwasaki Y. Bone mineral affinity of polyphosphodiesters. Molecules. 2020;25:758. doi: 10.3390/molecules25030758.
   PubMed Web of Science ®Google Scholar
• Boissy P, Saltel F, Bouniol C, et al. Transcriptional activity of nuclei in multinucleated osteoclasts and its modulation by calcitonin. Endocrinology. 2002;143(5):1913–1921. doi: 10.1210/endo.143.5.8813.
   PubMed Web of Science ®Google Scholar
• Edwards JR, Mundy GR. Advances in osteoclast biology: old findings and new insights from mouse models. Nat Rev Rheumatol. 2011;7(4):235–243. doi: 10.1038/nrrheum.2011.23.
   PubMed Web of Science ®Google Scholar
• Arai F, Miyamoto T, Ohneda O, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J Exp Med. 1999;190(12):1741–1754. doi: 10.1084/jem.190.12.1741.
   PubMed Web of Science ®Google Scholar
• Lee B, Jo S, Kim S-M, et al. Poly-γ-glutamic acid suppresses osteoclastogenesis in human osteoclast T precursors and prevents joint damage in a collagen-induced murine arthritis model. Immunol Lett. 2018;203:80–86. doi: 10.1016/j.imlet.2018.09.004.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim K, Youn BU, et al. MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR. Cell Signal. 2010;22(9):1341–1349. doi: 10.1016/j.cellsig.2010.05.001.
   PubMed Web of Science ®Google Scholar
• Iwasaki R, Ninomiya K, Miyamoto K, et al. Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity. Biochem Biophys Res Commun. 2008;377(3):899–904. doi: 10.1016/j.bbrc.2008.10.076.
   PubMed Web of Science ®Google Scholar
• Wilson SR, Peters C, Saftig P, et al. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. J Biol Chem. 2009;284(4):2584–2592. doi: 10.1074/jbc.M805280200.
   PubMed Web of Science ®Google Scholar
• Wang L, Li SY, Jiang W, et al. Polyphosphoestered nanomedicines with tunable surface hydrophilicity for cancer drug delivery. ACS Appl Mater Interf. 2020;12(29):32312–32320. doi: 10.1021/acsami.0c07016.
   PubMed Web of Science ®Google Scholar